Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Wood

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Science of the Total Environment|February 11, 2026
Housing age and sociodemographic characteristics as predictors of residential lead exposure and modeled child blood lead levelsAlyson Alde, Michelle Del Rio, Jennifer Hoponick Redmon, et al.
Environmental Science & Technology|August 7, 2025
PFAS in Rural U.S. Well Water: Using Participatory Science to Identify and Communicate Results to Address RisksErica Wood, Riley E Mulhern, Jacqueline MacDonald Gibson, et al.
British Journal of Haematology|November 8, 2025
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases RegistrySueh-Li Lim, Cameron Wellard, Rajeev Rajagopal, et al.
Journal of Paediatrics and Child Health|December 9, 2020
Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatriciansRyan Lucas, Peta Dennington, Erica Wood, et al.
Blood Reviews|July 21, 2023
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic reviewAllison Mo, Matthew Poynton, Erica Wood, et al.
Seminars in Thrombosis and Hemostasis|December 20, 2018
Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort StudyMing Sheng Lim, Tishya Indran, Anita Cummins, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2021
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR)Krystal Bergin, Cameron Wellard, Elizabeth Moore, et al.
American Journal of Public Health|September 30, 2022
Lead Levels in Tap Water at Licensed North Carolina Child Care Facilities, 2020-2021Jennifer Hoponick Redmon, A J Kondash, Ed Norman, et al.
British Journal of Haematology|July 12, 2022
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)Zoe McQuilten, Cameron Wellard, Elizabeth Moore, et al.
Bone Marrow Transplantation|May 20, 2021
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)Krystal Bergin, Cameron Wellard, Bradley Augustson, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Science of the Total Environment|February 11, 2026
Housing age and sociodemographic characteristics as predictors of residential lead exposure and modeled child blood lead levelsAlyson Alde, Michelle Del Rio, Jennifer Hoponick Redmon, et al.
Environmental Science & Technology|August 7, 2025
PFAS in Rural U.S. Well Water: Using Participatory Science to Identify and Communicate Results to Address RisksErica Wood, Riley E Mulhern, Jacqueline MacDonald Gibson, et al.
British Journal of Haematology|November 8, 2025
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases RegistrySueh-Li Lim, Cameron Wellard, Rajeev Rajagopal, et al.
Journal of Paediatrics and Child Health|December 9, 2020
Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatriciansRyan Lucas, Peta Dennington, Erica Wood, et al.
Blood Reviews|July 21, 2023
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic reviewAllison Mo, Matthew Poynton, Erica Wood, et al.
Seminars in Thrombosis and Hemostasis|December 20, 2018
Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort StudyMing Sheng Lim, Tishya Indran, Anita Cummins, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2021
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR)Krystal Bergin, Cameron Wellard, Elizabeth Moore, et al.
American Journal of Public Health|September 30, 2022
Lead Levels in Tap Water at Licensed North Carolina Child Care Facilities, 2020-2021Jennifer Hoponick Redmon, A J Kondash, Ed Norman, et al.
British Journal of Haematology|July 12, 2022
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)Zoe McQuilten, Cameron Wellard, Elizabeth Moore, et al.
Bone Marrow Transplantation|May 20, 2021
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)Krystal Bergin, Cameron Wellard, Bradley Augustson, et al.
Pageof 5